Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

1. López-Gálvez, R.
2. Rivera-Caravaca, J.M.
3. Anguita Sánchez, M.
4. Sanmartín Fernández, M.
5. Rafols, C.
6. Pérez-Cabeza, A.I.
7. Barón Esquivias, G.
8. Lekuona Goya, I.
9. Vázquez Rodríguez, J.M.
10. Cosín Sales, J.
11. Arribas Ynsaurriaga, F.
12. Barrios, V.
13. Freixa-Pamias, R.
14. Marín, F.